These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25982504)

  • 1. Neuroprotective effect of ultra-high dose methylcobalamin in wobbler mouse model of amyotrophic lateral sclerosis.
    Ikeda K; Iwasaki Y; Kaji R
    J Neurol Sci; 2015 Jul; 354(1-2):70-4. PubMed ID: 25982504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse.
    Ikeda K; Iwasaki Y
    PLoS One; 2015; 10(10):e0140316. PubMed ID: 26469273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials of ultra-high-dose methylcobalamin in ALS].
    Izumi Y; Kaji R
    Brain Nerve; 2007 Oct; 59(10):1141-7. PubMed ID: 17969354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nitric oxide synthase inhibitor, 7-nitroindazole, delays motor dysfunction and spinal motoneuron degeneration in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    J Neurol Sci; 1998 Sep; 160(1):9-15. PubMed ID: 9804111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice.
    Iwamoto K; Yoshii Y; Ikeda K
    Amyotroph Lateral Scler; 2009; 10(5-6):405-9. PubMed ID: 19922131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ultrahigh-dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: a double-blind controlled study.
    Kaji R; Kodama M; Imamura A; Hashida T; Kohara N; Ishizu M; Inui K; Kimura J
    Muscle Nerve; 1998 Dec; 21(12):1775-8. PubMed ID: 9843082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
    Dave KR; Raval AP; Purroy J; Kirkinezos IG; Moraes CT; Bradley WG; Pérez-Pinzón MA
    Neurobiol Dis; 2005 Feb; 18(1):126-33. PubMed ID: 15649703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease.
    Ikeda K; Iwasaki Y; Tagaya N; Shiojima T; Kobayashi T; Kinoshita M
    Neurol Res; 1995 Dec; 17(6):445-8. PubMed ID: 8622800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-588, a novel neuroprotective agent, delays progression of neuromuscular dysfunction in wobbler mouse motoneuron disease.
    Ikeda K; Iwasaki Y; Kinoshita M; Marubuchi S; Ono S
    Brain Res; 2000 Mar; 858(1):84-91. PubMed ID: 10700601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-high-dose methylcobalamin in amyotrophic lateral sclerosis: a long-term phase II/III randomised controlled study.
    Kaji R; Imai T; Iwasaki Y; Okamoto K; Nakagawa M; Ohashi Y; Takase T; Hanada T; Shimizu H; Tashiro K; Kuzuhara S
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):451-457. PubMed ID: 30636701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis.
    Kaji R; Izumi Y; Oki R
    Curr Opin Neurol; 2024 Oct; 37(5):593-602. PubMed ID: 39083229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse.
    Saberi D; Ott B; Dahlke C; Matschke V; Schmitt-John T; Theiss C
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):347-57. PubMed ID: 26945034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse.
    Ikeda K; Iwasaki Y; Kinoshita M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):207-12. PubMed ID: 11464954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
    Oki R; Izumi Y; Fujita K; Miyamoto R; Nodera H; Sato Y; Sakaguchi S; Nokihara H; Kanai K; Tsunemi T; Hattori N; Hatanaka Y; Sonoo M; Atsuta N; Sobue G; Shimizu T; Shibuya K; Ikeda K; Kano O; Nishinaka K; Kojima Y; Oda M; Komai K; Kikuchi H; Kohara N; Urushitani M; Nakayama Y; Ito H; Nagai M; Nishiyama K; Kuzume D; Shimohama S; Shimohata T; Abe K; Ishihara T; Onodera O; Isose S; Araki N; Morita M; Noda K; Toda T; Maruyama H; Furuya H; Teramukai S; Kagimura T; Noma K; Yanagawa H; Kuwabara S; Kaji R;
    JAMA Neurol; 2022 Jun; 79(6):575-583. PubMed ID: 35532908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [JETALS: The Japanese Early-stage Trial of high dose methylcobalamin for ALS].
    Izumi Y; Oki R; Kuwabara S; Kaji R
    Brain Nerve; 2019 Nov; 71(11):1261-1269. PubMed ID: 31722312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment.
    Ott B; Dahlke C; Meller K; Napirei M; Schmitt-John T; Brand-Saberi B; Theiss C; Saberi D
    Ann Anat; 2015 Jul; 200():118-24. PubMed ID: 25929815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Selective Glucocorticoid Receptor Modulator Cort 113176 Reduces Neurodegeneration and Neuroinflammation in Wobbler Mice Spinal Cord.
    Meyer M; Lara A; Hunt H; Belanoff J; de Kloet ER; Gonzalez Deniselle MC; De Nicola AF
    Neuroscience; 2018 Aug; 384():384-396. PubMed ID: 29890290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease.
    Ikeda K; Kinoshita M; Iwasaki Y; Tagaya N; Shiojima T
    Neuromuscul Disord; 1995 Sep; 5(5):383-90. PubMed ID: 7496172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis.
    Lara A; Esperante I; Meyer M; Liere P; Di Giorgio N; Schumacher M; Guennoun R; Gargiulo-Monachelli G; De Nicola AF; Gonzalez Deniselle MC
    Mol Neurobiol; 2021 May; 58(5):2088-2106. PubMed ID: 33411236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.